Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Nectar Lifesciences Limited
NECLIFE | NSE
10.04
INR0.28
2.87%
NECLIFE | NSE
Loading StockChartView...
About Nectar Lifesciences Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
02/04/2026
Close
10.04
Open
9.99
High
10.23
Low
9.71
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company's active pharmaceutical ingredients and intermediates comprise cefixime cefuroxime axetil amorphous cefuroxime axetil crystalline cefotaxime sodium ceftriaxone sodium cefixime trihydrate cefuroxime axetil cefpodoxime proxetil and sterile cefprozil cefdinir cefuroxime sodium cefazolin sodium ceftazidime pentahydrate and cefepime +Arginine. The company also offers contract manufacturing for finished dosage forms such as tablets capsules dry powder oral suspensions and granules and injectable for cephalosporins. In addition it provides phytochemicals and empty hard gelatin capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh India.
View LessNECLIFE | NSE
Risk
42.3
Sharpe
-1.00
Luna's Score
39/100
Recommendation
Sell
Luna says (NECLIFE | NSE)
What's Working
Strength based on increasing price with high volume
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
55.5%1 month
42.3%3 months
40.1%6 months
62.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
138.07
Fwd. PE
-
Price to book
0.78
Debt to equity
0.59
Debt to assets
0.29
Ent. to EBITDA
8.38
Ent. to rev.
0.88
PEG
-
Other Fundamentals
EBITDA
1.58B
MarketCap
2.28B
MarketCap(USD)
24.46M
Div. yield
-
Op. margin
6.78
Erngs. growth
62.50
Rev. growth
-8.90
Ret. on equity
0.47
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
2.12
Range1M
2.85
Range3M
11.60
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.28
Price X volume
5.99M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 8.38 | 24.85 | Cheaper |
| Ent. to Revenue | 0.88 | 11.40 | Cheaper |
| PE Ratio | 138.07 | 51.36 | Expensive |
| Price to Book | 0.78 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 40.15 | 42.17 | Par |
| Debt to Equity | 0.59 | 0.35 | Expensive |
| Debt to Assets | 0.29 | 0.17 | Expensive |
| Market Cap | 2.28B | 290.82B | Emerging |
